论文部分内容阅读
在美国波士顿举行的全球器官芯片会议上,许多医药和生物技术公司以及学术界研究人员展示了微型器官模型的最新进展,推崇这项襁褓中技术的研究人员们认为,这种正在研发塑料芯片上的人类器官微缩模型,可以作为动物模型的替代品。虽然这个目标依然很遥远,但随着大型医药公司在药物研发中使用这些体外系统,该技术越来越受到关注。荷兰莱顿Mimetas生物技术公司创始人之一Paul Vulto说,“我们对来自制药公司的关注感
At the Global Organ Chip Conference in Boston, USA, many pharmaceutical and biotech companies and academics showcased the latest advances in micro organ models. Researchers who respected this boisterous technology argue that this is being developed on plastic chips Miniature model of human organs, can be used as a substitute for animal models. Although this goal is still far off, the technology is gaining traction as large pharmaceutical companies use these in vitro systems for drug discovery. Paul Vulto, one of the founders of Mimetas Biotech in Leiden, the Netherlands, said, ”We are concerned about the sense of concern